Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
499.40    -0.60 (-0.12%)
Bid:
500.00
Ask:
501.00
Spread: 1.00 (0.20%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Appointment of non-executive director

4 Mar 2026 07:00

RNS Number : 1803V
Chemring Group PLC
04 March 2026
 

FOR IMMEDIATE RELEASE 4 MARCH 2026

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

DIRECTORATE CHANGE

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Chemring today announces the appointment of Baroness Kate Rock as an independent non-executive director. Upon joining the Board, Kate will become the Senior Independent Director and a member of the Audit, Nomination and Remuneration Committees. She will join the Board with effect from 1 April 2026.

 

Kate is an experienced non?executive director with a board portfolio covering technology, engineering, construction and infrastructure. Underpinned by a strong background in corporate communications and strategy, she combines deep engineering sector knowledge with a strategic understanding of how innovation and technology enhance productivity, together with wide-ranging experience working across government.

 

On 1 December 2022 Kate was appointed Non-Executive Chair of the UK infrastructure solutions company Costain Group PLC. Since that time Costain has seen a near five-fold increase in its share price and has re-entered the FTSE 250 index. In September 2018 she joined the Board of FTSE 250 Keller Group plc (the world's largest geotechnical specialist contractor) and is now the Senior Independent Director, serving on the Audit & Risk, Nomination & Governance, Remuneration and Sustainability Committees.

 

Having been appointed a Life Peer in 2015, she sat on the House of Lords Science and Technology Select Committee until January 2023. She was also a member of the House of Lords Select Committee on Artificial Intelligence from 2017 to 2018 and was Chair of the House of Lords Select Committee on Autism between January and November 2025.

 

Until January 2023, Kate was a Board member of the world's first Centre for Data Ethics and Innovation and was, until November 2017, a non-executive director of Imagination Technologies plc, the former global FTSE 250 high technology company.

 

Tony Wood, Chairman of Chemring, commented:

"Following an extensive selection process, I am delighted to welcome Baroness Rock to Chemring. Kate brings considerable experience within the fields of technology, infrastructure and innovation, as well as government and strategic communications. Her strong understanding of the construction and infrastructure sector will also be of value to the Group as we further progress our organic growth strategy and investment in increased capacity. I am certain that she will make a strong contribution to the continued development and performance of the Group."

 

There are no further disclosures required to be made in accordance with UKLR 6.4.8 of the FCA's UK Listing Rules sourcebook.

 

-ENDS-

 

For further information:

Rupert Pittman Group Director of Corporate Affairs, 01794 463401

Chemring Group PLC

 

James McFarlane MHP Group 07584 142665

Ollie Hoare 07817 458804

 

Notes to editors

 

· Chemring is a FTSE-250 global business that specialises in the manufacture of high technology products and the provision of services to the defence, security and aerospace markets

· Employing approximately 2,700 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFBQXLFBBD
Date   Source Headline
3rd Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20267:02 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim results
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20262:36 pmRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
21st May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20263:46 pmRNSDirector/PDMR Shareholding
19th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20267:00 amRNSAppointment of non-executive director
2nd Mar 20269:15 amRNSTotal Voting Rights
20th Feb 20262:48 pmRNSResult of AGM
20th Feb 20267:00 amRNSAGM Update
16th Feb 20267:00 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:41 pmRNSDirector/PDMR Shareholding
12th Jan 20261:35 pmRNSNotice of AGM
2nd Jan 202610:29 amRNSTotal Voting Rights
19th Dec 202511:53 amRNSHolding(s) in Company
19th Dec 202511:53 amRNSHolding(s) in Company
18th Dec 20257:00 amRNSBlock listing Interim Review
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
15th Dec 20258:42 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20253:01 pmRNSAdditional Listing - Replacement
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 202512:41 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:38 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSAdditional Listing
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20254:23 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSResults for the year ended 31 October 2025
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.